跳至主要内容
临床试验/CTRI/2024/11/077072
CTRI/2024/11/077072尚未招募3 期

Effectiveness of Individualized Homoeopathic Medicine in the Management of Osteoarthritis: A single arm clinical study

Government of Uttar Pradesh1 个研究点 分布在 1 个国家目标入组 175 人开始时间: 2025年1月1日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
175
试验地点
1
主要终点
Osteoarthritis Quality of life score (OA Qol)

研究概览

简要总结

Osteoarthritis is primarily disease of elderly affecting mostly the hip and knee joint. It is a degenerative disease which affects the articular cartilage in the joints gradually and eventually destroys it, leaving the affected person unable to perform the routine work.  Pain is the main complain of patients to seek medical attention is pain. The pain also impacts the quality of life. The conventional approach for osteoarthritis is pain management with painkillers, pain-relieving lotions and non-steroidal anti-inflammatory medicines (NSAIDs), but these have a number of adverse effects, including renal failure and gastritis.  homeopathic medicine is that it is having no side effects and is cost effective. There are many studies in homoeopathy which shows effectiveness homoeopathic treatment in osteoarthritis having no side effect and is cost effective. Hence, this proposed study is an attempt to study the scope of individualized homoeopathic medicine in the management of Osteoarthritis in improve quality of life and reducing symptoms intensity of OA such as the pain and improving the activity of daily.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
40.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Clinically diagnosed cases having symptoms of osteoarthritis If patient was taking any acute medicine, he/she was included in the study after a washout Patients willing to give consent either by signature or thumb impressions.

排除标准

  • Patients with disability, bed- ridden patients are excluded.
  • Osteoarthritis associated with any uncontrollable chronic and systemic disease.

结局指标

主要结局

Osteoarthritis Quality of life score (OA Qol)

时间窗: 0, 6 and 12 months

次要结局

  • Improvement in symptoms(0, 6, 12 months)

研究者

发起方
Government of Uttar Pradesh
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Dr Hemlata

State Lal Bahadur Shastri Homoeopathic Medical College and Hospital

研究点 (1)

Loading locations...

相似试验